Member access

4-Traders Homepage  >  Shares  >  Johannesburg Stock Exchange  >  Aspen Pharmacare Holdings Limited    APNJ   ZAE000066692

 SummaryChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Johannesburg Stock Exchan…
01/26/2015 01/27/2015 01/28/2015 01/29/2015 01/30/2015 Date
443 433.01 435 438.22 438.61 Last
871180 1279120 909142 553331 817721 Volume
+2.03% -2.26% +0.46% +0.74% +0.09% Change
Company
Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical, healthcare and nutritional products.Its prescription branded products include Altosec, which is used for the treatment of ulcerative conditions of the gastrointestinal tract; Aspen Efavirenz and Lamzid for... 
Sector
Pharmaceuticals
Calendar
03/05Earnings Release
More about the company
Surperformance© ratings of Aspen Pharmacare Holdings
Trading Rating : Investor Rating :
More Ratings
Chart ASPEN PHARMACARE HOLDINGS
Duration : Period :
Aspen Pharmacare Holdings  Technical Analysis Chart | APNJ | ZAE000066692 | 4-Traders
Full-screen chart
Financials ( ZAR)
Sales 2015 36 787 M
EBIT 2015 9 354 M
Net income 2015 6 079 M
Debt 2015 25 217 M
Yield 2015 0,58%
Sales 2016 40 466 M
EBIT 2016 10 783 M
Net income 2016 7 414 M
Debt 2016 19 754 M
Yield 2016 0,71%
PER 2015 31,99
PER 2016 26,35
EV / Sales 2015 6,13x
EV / Sales 2016 5,43x
Capitalization 200 159 M
More Financials
Latest news on ASPEN PHARMACARE HOLDINGS
01/26 ASPEN PHARMACARE : Acquisition of rights to an anti-coagulant product from Novar..
01/16 ASPEN PHARMACARE : New drugs added to pharmacare coverage
01/14 ASPEN PHARMACARE : Manitoba adds almost 100 new medications to be covered under ..
01/08 ASPEN PHARMACARE : Mediclinic prop up JSE's winning run
01/08 ASPEN PHARMACARE : Mediclinic prop up JSE's winning run
01/08 ASPEN PHARMACARE : Mediclinic prop up JSE's winning run
01/08 ASPEN PHARMACARE : Mediclinic prop up JSE's winning run
2014 ASPEN PHARMACARE : PEX Report: Index Resumes Upward Trend by Almost 4 Points
More news
Sector news Generic Pharmaceuticals
01/31 JOHNSON & JOHNSON : Former FDA chief calls J&J misleading on Risperdal
01/30 SANOFI : 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana..
01/30 ABBVIE : breakup with Shire torpedoes 4th quarter, 2014 results
Plus d'actualités du secteur Generic Pharmaceuticals


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF